Our CEO Vivienne Williams talks about LES 2018 and why IP is important for Cellix, for biotech start-ups in general, and for industry, innov

So after all the hype, here we are! We here at Cellix are delighted to announce our re-brand, a reflection of the changing capacities of...

In the first of a series, our technical team discuss topics around transfection and gene editing. We start with a run down of 5 factors whic

History and Applications of Flow Cytometry Flow cytometry was born out of impedance technology; in 1953, a patent was issued to American...